Dalteparin

Dalteparin is a low molecular weight heparin (LMWH) used as an anticoagulant, which is a medication that prevents blood clots from forming. It is derived from the heparin molecule and has a longer half-life, allowing for once or twice daily injections.
Dalteparin is primarily used to prevent and treat deep vein thrombosis (DVT), a condition where blood clots form in the deep veins of the legs. DVT can lead to serious complications, such as pulmonary embolism, which is when a blood clot travels to the lungs and can be life-threatening.
The medication is also used to treat and prevent pulmonary embolism and reduce the risk of recurrent blood clots in patients with a history of clotting disorders. Additionally, Dalteparin may be prescribed to patients undergoing certain surgeries or procedures to minimize the risk of clot formation.
Dalteparin is typically administered as a subcutaneous injection, usually in the abdomen, thigh, or upper arm. The dosage and duration of treatment depend on the patient’s condition and the specific indication for which the medication is being used. Regular monitoring of blood clotting parameters is necessary during treatment to ensure the medication is working effectively and to avoid excessive anticoagulation.
Dalteparin may cause bleeding complications, particularly in patients with a history of bleeding disorders or who are taking other medications that increase the risk of bleeding. Patients should report any unusual bruising or bleeding to their healthcare provider immediately.